Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2024-04-25 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
普莱柯对会计师事务所2023年度履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the accounting firm (立信会计师事务所) for the year 2023. It discusses the audit firm's qualifications, the audit engagement process, and the quality of the audit work performed for the company's 2023 financial statements and internal control audit. The document is an assessment of the auditor's performance rather than the audit report itself or the full annual report. It does not contain financial statements or detailed financial data but rather an evaluation of the auditor's work. This fits the definition of an Audit Report / Information (AR) filing, which includes standalone audit reports and evaluations related to audit activities, excluding full annual reports. The document length is short (1196 characters), but it is not merely an announcement or certification; it is a substantive evaluation report. Therefore, the appropriate classification is AR with high confidence.
2024-04-25 Chinese
普莱柯董事会审计委员会2023年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from the Board Audit Committee of 普莱柯生物工程股份有限公司 for the year 2023. It describes the committee's composition, meetings, supervision of external auditors, review of financial reports, internal audit work, internal control effectiveness, and overall evaluation. The content focuses on audit committee activities and oversight rather than presenting standalone audit opinions or accounting principles. It is not a full Annual Report (10-K) or an Audit Report (AR) in the strict sense but rather a committee report on audit-related duties and governance. Given the nature of the document as a report on the audit committee's work and oversight, it fits best under Audit Report / Information (AR). The document length (2823 characters) is sufficient to contain substantive content, not just an announcement or certification. Therefore, the classification is AR with high confidence.
2024-04-25 Chinese
普莱柯2023年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2023年度内部控制评价报告' which translates to '2023 Annual Internal Control Evaluation Report'. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2023, including financial and non-financial internal control defects, their identification, and rectification status. The document is detailed and contains substantive information about internal control evaluation, which is a type of audit-related report but not a full annual report (10-K). It is not a simple announcement or certification but a comprehensive internal control evaluation report. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and internal control evaluations. The document length is 4659 characters, which is sufficient for a detailed report rather than a brief announcement. Therefore, the appropriate classification is AR with high confidence.
2024-04-25 Chinese
普莱柯关于向银行申请综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 普莱柯生物工程股份有限公司 regarding the application for a comprehensive credit facility from banks, detailing the credit limits, types of credit, and authorization by the board. It does not contain financial statements or results but is an update on financing activities and capital structure optimization. The document length is short (737 characters) and it is clearly an announcement of a financing update rather than a full financial report. Therefore, it fits the category of Capital/Financing Update (CAP).
2024-04-25 Chinese
普莱柯2023年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2023 Annual Report Summary" of Pulike Bioengineering Co., Ltd. It contains detailed financial data for the year 2023, including total assets, net profit, revenue, quarterly financial data, shareholder information, and business overview. It also references an audit report with an unqualified opinion by a CPA firm. The document is comprehensive and covers company operations, financial performance, and shareholder structure for the full fiscal year. It is not a brief announcement or a certification letter but a substantive financial report. Therefore, it fits the definition of an Annual Report (10-K).
2024-04-25 Chinese
普莱柯关于召开2023年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2023 Annual General Meeting (AGM) of 普莱柯生物工程股份有限公司, including the date, voting methods, agenda items, and proxy voting instructions. It contains no financial statements or detailed financial analysis but focuses on the meeting logistics and agenda. The document length is under 5,000 characters and primarily serves as a meeting notice and proxy form. Therefore, it is classified as AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM.
2024-04-25 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.